Authors
Loading...
Ex vivo study reveals elevated placental sVEGFR-1 suppresses angiogenesis in preeclampsia, suggesting a novel therapeutic target.
Ahmad et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: